- Scrip Originals
Brought to you by
CNS drug developer Axsome nets $47.4mm in IPO
20 Nov 2015
Axsome Therapeutics Inc. (CNS drug candidates) netted $47.4mm in its initial public offering of 5.7mm shares at $9. The company planned to sell 4.25mm shares at $11-13.
Already a Biomedtracker subscriber? You have access to the full deal record through your subscription
Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com